Latest filing published 26 Jan 2017 for BIOCEPT INC, €909k.
Insider track record
Ally Bridge LB Healthcare Master Fund Ltd: trading record in brief
Ally Bridge LB Healthcare Master Fund Ltd discloses dealings in Biocept Inc to SEC (Form 4). Between 17 January 2017 and 19 January 2017, the trades on record add up to 3 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 26 January 2017 came the latest disclosure, a transaction for €909k in Biocept Inc. Filings reach the SEC (Form 4) feed a median of 8 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Ally Bridge LB Healthcare Master Fund Ltd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 876,399 shares@ US$1.1052.3% of flowCommon StockSEC:0000899243-17-001973:0
- 549,708 shares@ US$1.1032.5% of flowCommon StockSEC:0000899243-17-001973:1
- 254,893 shares@ US$1.1015.2% of flowCommon StockSEC:0000899243-17-001973:2
3 of 3 declarations